| Year |
Citation |
Score |
| 2023 |
Masson HO, Samoudi M, Robinson CM, Kuo CC, Weiss L, Shams Ud Doha K, Campos A, Tejwani V, Dahodwala H, Menard P, Voldborg BG, Robasky B, Sharfstein ST, Lewis NE. Inferring secretory and metabolic pathway activity from omic data with secCellFie. Metabolic Engineering. PMID 38145748 DOI: 10.1016/j.ymben.2023.12.006 |
0.62 |
|
| 2023 |
Cordova LT, Dahodwala H, Cooley R, Lee KH. Prediction of CHO cell line stability using expression of DNA repair genes. Biotechnology Journal. e2300425. PMID 37970758 DOI: 10.1002/biot.202300425 |
0.307 |
|
| 2023 |
Masson HO, Samoudi M, Robinson CM, Kuo CC, Weiss L, Ud Doha KS, Campos A, Tejwani V, Dahodwala H, Menard P, Voldborg BG, Sharfstein ST, Lewis NE. Inferring secretory and metabolic pathway activity from omic data with secCellFie. Biorxiv : the Preprint Server For Biology. PMID 37205389 DOI: 10.1101/2023.05.04.539316 |
0.621 |
|
| 2022 |
Cordova LT, Dahodwala H, Elliott KS, Baik J, Odenewelder DC, Nmagu D, Skelton BA, Uy L, Klaubert SR, Synoground BF, Chitwood DG, Dhara VG, Naik HM, Morris CS, Yoon S, et al. Generation of reference cell lines, media, and a process platform for CHO cell biomanufacturing. Biotechnology and Bioengineering. PMID 36411514 DOI: 10.1002/bit.28290 |
0.406 |
|
| 2022 |
Dahodwala H, Amenyah SD, Nicoletti S, Henry MN, Lees-Murdock DJ, Sharfstein ST. Evaluation of site-specific methylation of the CMV promoter and its role in CHO cell productivity of a recombinant monoclonal antibody. Antibody Therapeutics. 5: 121-129. PMID 35719211 DOI: 10.1093/abt/tbac010 |
0.558 |
|
| 2019 |
Dahodwala H, Kaushik P, Tejwani V, Kuo CC, Menard P, Henry M, Voldborg BG, Lewis NE, Meleady P, Sharfstein ST. Increased mAb production in amplified CHO cell lines is associated with increased interaction of CREB1 with transgene promoter. Current Research in Biotechnology. 1: 49-57. PMID 32577618 DOI: 10.1016/j.crbiot.2019.09.001 |
0.65 |
|
| 2019 |
Dahodwala H, Lee KH. The fickle CHO: a review of the causes, implications, and potential alleviation of the CHO cell line instability problem. Current Opinion in Biotechnology. 60: 128-137. PMID 30826670 DOI: 10.1016/J.Copbio.2019.01.011 |
0.417 |
|
| 2017 |
Dahodwala H, Sharfstein ST. Biosimilars: Imitation Games. Acs Medicinal Chemistry Letters. 8: 690-693. PMID 28740599 DOI: 10.1021/Acsmedchemlett.7B00199 |
0.571 |
|
| 2017 |
Dahodwala H, Sharfstein ST. The 'Omics Revolution in CHO Biology: Roadmap to Improved CHO Productivity. Methods in Molecular Biology (Clifton, N.J.). 1603: 153-168. PMID 28493129 DOI: 10.1007/978-1-4939-6972-2_10 |
0.631 |
|
| 2015 |
Baik JY, Dahodwala H, Oduah E, Talman L, Gemmill TR, Gasimli L, Datta P, Yang B, Li G, Zhang F, Li L, Linhardt RJ, Campbell AM, Gorfien SF, Sharfstein ST. Optimization of bioprocess conditions improves production of a CHO cell-derived, bioengineered heparin. Biotechnology Journal. 10: 1067-81. PMID 26037948 DOI: 10.1002/Biot.201400665 |
0.638 |
|
| 2014 |
Dahodwala H, Sharfstein ST. Role of epigenetics in expression of recombinant proteins from mammalian cells Pharmaceutical Bioprocessing. 2: 403-419. DOI: 10.4155/Pbp.14.47 |
0.63 |
|
| 2012 |
Dahodwala H, Nowey M, Mitina T, Sharfstein ST. Effects of clonal variation on growth, metabolism, and productivity in response to trophic factor stimulation: a study of Chinese hamster ovary cells producing a recombinant monoclonal antibody. Cytotechnology. 64: 27-41. PMID 21822681 DOI: 10.1007/S10616-011-9388-Z |
0.606 |
|
| Show low-probability matches. |